VNDA Vanda Pharmaceuticals Inc.
$3.99▲ +1.27%
Healthcare
Other
After hours
$3.96▼ -0.88%
Oct 27, 5:55 PM ET
Volume 1.86M
Avg Volume (10D) 877.3K
Key Metrics & Fundamentals
Market Cap
$241.25M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.88 - 9.94
% vs 50 MA
-18.26%
% vs 200 MA
-36.34%
RSI-14
29.7
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.75
Free Cash Flow
-$31.26M
Gross Rev
$50.53M
Gross Profit
$46.97M
EBITDA
-$60.10M
COGS
$3.56M
Operating Exp
$110.78M
Operating Income
-$63.81M
EBIT
-$63.81M
Pretax Income
-$62.38M
Net Income
-$62.51M
EPS (Diluted)
-1.04
Price & Volume History
Loading chart…
Recent News
Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting
PR Newswire · Oct 27, 2026 6:50 AM ET
Fortrea Holdings Inc. (FTRE) Earnings Expected to Grow: Should You Buy?
Zacks · Oct 22, 2026 9:00 AM ET
Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026
PR Newswire · Oct 21, 2026 5:40 PM ET
XENE's Depression Trial Setback: Is Its Pipeline Still Attractive?
Zacks · Oct 15, 2026 12:05 PM ET
Vanda puts anxiety drug’s development on ice after Phase III fail
Clinical Trials Arena · Oct 15, 2026 7:33 AM ET
Vanda Pharmaceuticals stock falls after anxiety drug trial fails
Investing.com · Oct 14, 2026 5:54 PM ET
Vanda Pharmaceuticals' Late-Stage Study of VQW-765 to Treat Acute Anxiety Fails to Meet Primary Endpoint
MT Newswires · Oct 14, 2026 5:35 PM ET
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
PR Newswire · Oct 14, 2026 5:00 PM ET
Vanda Pharmaceuticals Announces Presentation at 2026 EADV Annual Meeting
PR Newswire · Oct 2, 2026 9:06 AM ET
VNDA Stock Fades After Hetlioz Sleep-Trial Win — Here’s Why
Stocktwits · Sep 30, 2026 1:27 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See VNDA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.